- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07769632
Total Osteo-Cartilage Replacement for the Treatment of Osteoarthritis of Knee
18. august 2026 opdateret af: Sadat A Ali, AlSalam Hospital
Young patients who require total knee arthroplasty with metallic and plastic implants will undergo femoral condyle cartilage and top of the tibia with meniscus replacement.
With the proposed surgery patients will have increased range of movements so that they can sit on the ground to fulfill their social was of life, which is not possible with the standard of care total knee replacement.
Studieoversigt
Status
Ikke rekrutterer endnu
Betingelser
Detaljeret beskrivelse
Detailed Description Procedure for the TOCR: A cruciate knee replacement requires less bone and soft tissue resection.
A more normal transmission of the weight-bearing stresses is possible compared to other knee Measures of Treatment Compliance: None.
Study Procedures and Guidelines: replacements.
Preserving both cruciate ligaments mandates the correct tension on all ligaments.
Bi-cruciate retaining (BCR) TKA is considered to show improved clinical function and kinematics.The standard technique of the Bi-cruciate retaining (BCR) TKA is described.
The importance of retaining both the cruciate ligaments cannot be over emphasized.
In TOCR both the cruciate ligaments retained are native.
The Cruciate ligaments, particularly the Anterior Cruciate Ligament (ACL), are vital for knee proprioception, acting as specialized sensors that inform the brain about knee position, movement, and load.
They contain mechanoreceptors that initiate reflex muscle contractions to stabilize the joint.
In standard TKR both the cruciate are removed making the stability on the implants.
Figure I gives the standard cuts of the Femur and Tibia using the routine instrumentation of the Bi-cruciate retaining (BCR) TKA.
During regular TKR, the bone segments removed are discarded, and this will follow the same procedure as TOCR.
TOCR uses standard instrumentation of the bi-cruciate retaining TKR.
All the cuts and procedures are similar to the TKR.
Instead of metallic and polyethylene implants, a custom-matched Allograft of the femoral cartilage and Tibial plateau will be performed.
The Allograft will be fixed with 2 Acutrak 2, 7.5mm X 120mm long, in the femur and tibia.
The menisci will be sutured to the capsule of the native joint.
The custom-matched allografts will be obtained by MTF Biologics, New Jersey, USA.The surgeons will carry out the initial 10 cases, and the cost will be borne by the Patent.
Will take liability medical insurance for the patients to be treated if there are any complications.
If the TOCR fails patients will undergo standard TKR and will be covered by the Insurance and Sponsors.
The failure of the procedure could be infection which will be treated by antibiotics on out patient basis.
As postoperatively patients will have routine physical therapy to strengthen the muscles and proper gait training for one month.
The there is a failure of union then a bone graft can be further augmented and worse is to take out the allografts and perform the standard Total knee replacement.
All patients will be instructed to report immediately to the hospital if any side effects are noted.
Depending on the adverse effects, patients will continue or stop further treatment.
All patients without or with adverse events will be followed for 36 months from the time they were operated on.
All Adverse Events (AEs) were noted at every visit and were graded based on the intensity (mild, moderate, or severe) and relevance (serious, non-serious).
Standard cuts of the Femur or Tibia in TKR.
Schematic image of the post fixation in TOCR.
Cadaveric Allografts of the Femur and Tibial Plateau.
FIGURE I: Standard cuts of the Femur or Tibia in TKR.FIGURE II: Schematic image of the post fixation in TOCR Cadaveric TOCR. Figure IV: Cadaveric Allografts of the Femur and Tibial Plateau after fixation.
Post-surgery patients will have the routine mobilization protocol by physical therapy as for standard TKR.
Undersøgelsestype
Interventionel
Tilmelding (Anslået)
10
Fase
- Tidlig fase 1
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiekontakt
- Navn: Jamal Saleh, FRCS
- Telefonnummer: +97336599999
- E-mail: drjslaeh@gmail.com
Studiesteder
-
-
-
Manama, Bahrain, 80278
- AlSalam Specialist Hospital
-
Kontakt:
- Jamal Saleh, FRCS,
- Telefonnummer: +97336599999
- E-mail: drjsaleh@gmail.com
-
Kontakt:
- Mir Sadat-Ali, FRCS, PhD
- Telefonnummer: +97339309939
- E-mail: drsadat@hotmail.com
-
Ledende efterforsker:
- Dr Jamal Saleh, FRCS
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Ingen
Beskrivelse
Inclusion Criteria:
- Being between 45 and 70 years of age of either gender. (OAK is common in this Age group)
- Diagnosed with OAK with Kellgren and Lawrence Grading III and IV.
- No ligamentous laxity and varus or valgus deformity. (In standard TKR patients with ligamentous laxity Constrained Condylar Knee (CCK) with intramedullary stem is used).
- Patients who wish to have an active lifestyle.
- Agreeing to participate and signing informed consent voluntarily.
Exclusion Criteria:
- Previous knee surgery within six months.
- Uncontrolled Diabetes Mellitus
- Chronic Kidney Disease. (Patients on hemodialysis)
- Metabolic bone disease. (Severe osteoporosis with T Score of -<3.5)
- Patients who will not consent to follow-up.
- Mental disorders and drug dependency (Patients who cannot understand the consent or the procedure of the TOCR).
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: For osteoarthritis of knee grade II and III
Total Osteo Cartilage replacement will be replaced using allogenic bone and cartilage graft with meniscus
|
IN total knee replacement metallic and plastic implant is used but in this procedure allograft with bone, cartilage and meniscus will be used.
Andre navne:
In this study allograft will be used instead of metallic and plastic implants.
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Assessment of Allograft in osteoarthritis of knee
Tidsramme: 36 months
|
The outcome of the allograft will be assessed by union of the allograft with the native bone.
|
36 months
|
|
assessment range of movements using WOMAC (Western Ontario University McMaster Osteoarthritis Index) .
Tidsramme: 3,6,9,12, 18, 24 and 36 months.
|
pain=0-20, stiffness=0-8, physical function=0-68.
a total WOMAC score is created by summing the items for all three subscales (max score 96).
|
3,6,9,12, 18, 24 and 36 months.
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Studieleder: Mir Sadat-Ali, FRCS, PhD, US Consultancy for Applied Research
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Generelle publikationer
- Gelber PE, Erquicia JI, Ramirez-Bermejo E, Farinas O, Monllau JC. Fresh Osteochondral and Meniscus Allografting for Post-traumatic Tibial Plateau Defects. Arthrosc Tech. 2018 May 28;7(6):e661-e667. doi: 10.1016/j.eats.2018.02.010. eCollection 2018 Jun.
- Kaarre J, Herman ZJ, Zsidai B, Grassi A, Zaffagnini S, Samuelsson K, Musahl V. Meniscus allograft transplantation for biologic knee preservation: gold standard or dilemma? Knee Surg Sports Traumatol Arthrosc. 2023 Sep;31(9):3579-3581. doi: 10.1007/s00167-022-07187-w. Epub 2022 Oct 7. No abstract available.
- Southworth TM, Naveen NB, Tauro TM, Chahla J, Cole BJ. Meniscal Allograft Transplants. Clin Sports Med. 2020 Jan;39(1):93-123. doi: 10.1016/j.csm.2019.08.013.
- Gross AE, Shasha N, Aubin P. Long-term followup of the use of fresh osteochondral allografts for posttraumatic knee defects. Clin Orthop Relat Res. 2005 Jun;(435):79-87. doi: 10.1097/01.blo.0000165845.21735.05.
- Volkov M. Allotransplantation of joints. J Bone Joint Surg Br. 1970 Feb;52(1):49-53. No abstract available.
- Gross AE, Silverstein EA, Falk J, Falk R, Langer F. The allotransplantation of partial joints in the treatment of osteoarthritis of the knee. Clin Orthop Relat Res. 1975 May;(108):7-14. doi: 10.1097/00003086-197505000-00003.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Anslået)
1. november 2026
Primær færdiggørelse (Anslået)
31. oktober 2027
Studieafslutning (Anslået)
31. oktober 2027
Datoer for studieregistrering
Først indsendt
17. juli 2026
Først indsendt, der opfyldte QC-kriterier
12. august 2026
Først opslået (Faktiske)
18. august 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
19. august 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
18. august 2026
Sidst verificeret
1. juli 2026
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- PH1-NHRA23-01
- Salmania Medical Complex (Anden identifikator: AlSalam Specialist Hospital)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
JA
IPD-planbeskrivelse
not decided yet
IPD-delingstidsramme
November 2026 to October 2027
IPD-delingsadgangskriterier
will share later
IPD-deling Understøttende informationstype
- STUDY_PROTOCOL
- SAP
- ICF
- CSR
Studiedata/dokumenter
-
Studieprotokol
Informations-id: dr jamal SalehOplysningskommentarer: www.nhra.bh, TOCR STUDY
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ja
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ja
produkt fremstillet i og eksporteret fra U.S.A.
Ja
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .